<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
Creso Pharma Ltd has secured two new purchase orders (POs) with a combined value of CHF230,000 (~A$337,577) in a move that will broaden its European market presence. The purchase orders have come from Swiss-based health products distributor MHG GmbH for CPH’s cannaQIX® hemp seed oil lozenges and cannaQIX® 50 lozenges.
...read full article on Proactive Investors
